- Home
- OGI vs FHTX Comparison
OGI vs FHTX Comparison
Compare OGI & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OGI | FHTX |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 171.3M | 111.1M |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | OGI | FHTX |
|---|---|---|
| Price | $0.93 | $2.03 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 10 |
| Target Price | $2.43 | ★ $4.17 |
| AVG Volume (30 Days) | 375.8K | ★ 1.2M |
| Earning Date | 08-11-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 25.32 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $30,909,000.00 |
| Revenue This Year | $34.95 | N/A |
| Revenue Next Year | $30.97 | $15.98 |
| P/E Ratio | $13.91 | ★ N/A |
| Revenue Growth | N/A | ★ 36.75 |
| 52 Week Low | $0.85 | $1.79 |
| 52 Week High | $2.24 | $7.61 |
Technical Indicators
Market Signals| Indicator | OGI | FHTX |
|---|---|---|
| Relative Strength Index (RSI) | 37.44 | 25.12 |
| Support Level | $0.91 | $1.79 |
| Resistance Level | $1.07 | $5.27 |
| Average True Range (ATR) | 0.03 | 0.14 |
| MACD | 0.00 | 0.11 |
| Stochastic Oscillator | 41.97 | 61.43 |
Price Performance
Historical ComparisonAbout OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.